Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Neoplasms × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 4 Pain 2 Chronic Pain 2 Breast Neoplasms 2 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neuralgia 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Breast Cancer Patient 1 Brain Neoplasms 1 Astrocytoma 1 Acute Pain 1

Interventions

Sorafenib 36 Bevacizumab 14 Oxaliplatin 13 Leucovorin 9 Fluorouracil 9 Doxorubicin 9 Hepatectomy 8 Gemcitabine 8 Cisplatin 8 Capecitabine 8 Radiosurgery 7 pembrolizumab 6 Radiofrequency Ablation 6 Nivolumab 6 Irinotecan 6 Drug Therapy 6 Carboplatin 6 Talaporfin 5 Mitomycin 5 Cryosurgery 5 spartalizumab 4 Melphalan 4 Everolimus 4 Erlotinib Hydrochloride 4 Embolization, Therapeutic 4 Electroporation 4 aldesleukin 3 Surveys and Questionnaires 3 Sunitinib 3 Sirolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03151213 2026-03-13

pregabalin

Tanta University

Phase 4 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡